Qi Sun

机构：Peking University, Wenzhou Medical University, Affiliated Eye Hospital of Wenzhou Medical College, Center for Life Sciences · ORCID：0000-0002-8519-657X

发表论文 87 篇 · 总被引 2038 次 · h-index 22

代表论文

• Bardoxolone and bardoxolone methyl, two Nrf2 activators in clinical trials, inhibit SARS-CoV-2 replication and its 3C-like protease (2021 · Signal Transduction and Targeted Therapy · 被引 57)
• Computer-Aided Drug Discovery for Undruggable Targets (2025 · Chemical Reviews · 被引 54)
• Visualizing single-molecule conformational transition and binding dynamics of intrinsically disordered proteins (2023 · Nature Communications · 被引 35)
• Accelerating discovery of bioactive ligands with pharmacophore-informed generative models (2025 · Nature Communications · 被引 29)
• Reinforced Immunogenic Endoplasmic Reticulum Stress and Oxidative Stress via an Orchestrated Nanophotoinducer to Boost Cancer Photoimmunotherapy (2024 · ACS Nano · 被引 26)
• Discovery of novel SARS-CoV-2 3CL protease covalent inhibitors using deep learning-based screen (2022 · European Journal of Medicinal Chemistry · 被引 21)